10X Genomics Inc
NASDAQ:TXG

Watchlist Manager
10X Genomics Inc Logo
10X Genomics Inc
NASDAQ:TXG
Watchlist
Price: 16.69 USD 1.15% Market Closed
Market Cap: 2.1B USD

Intrinsic Value

The intrinsic value of one TXG stock under the Base Case scenario is 21.93 USD. Compared to the current market price of 16.69 USD, 10X Genomics Inc is Undervalued by 24%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TXG Intrinsic Value
21.93 USD
Undervaluation 24%
Intrinsic Value
Price
Base Case Scenario

Valuation History
10X Genomics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about TXG?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TXG valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for 10X Genomics Inc.

Explain Valuation
Compare TXG to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TXG?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
10X Genomics Inc

Current Assets 659.8m
Cash & Short-Term Investments 482.1m
Receivables 96.6m
Other Current Assets 81.2m
Non-Current Assets 367.5m
PP&E 296.2m
Intangibles 69.3m
Other Non-Current Assets 2.1m
Current Liabilities 147.3m
Accounts Payable 18.1m
Accrued Liabilities 58.7m
Other Current Liabilities 70.5m
Non-Current Liabilities 94.9m
Other Non-Current Liabilities 94.9m
Efficiency

Free Cash Flow Analysis
10X Genomics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
10X Genomics Inc

Revenue
641.8m USD
Cost of Revenue
-199.6m USD
Gross Profit
442.2m USD
Operating Expenses
-576.7m USD
Operating Income
-134.5m USD
Other Expenses
58.2m USD
Net Income
-76.3m USD
Fundamental Scores

TXG Profitability Score
Profitability Due Diligence

10X Genomics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
ROE is Increasing
27/100
Profitability
Score

10X Genomics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

TXG Solvency Score
Solvency Due Diligence

10X Genomics Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Average Altman Z-Score
68/100
Solvency
Score

10X Genomics Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TXG Price Targets Summary
10X Genomics Inc

Wall Street analysts forecast TXG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TXG is 17.54 USD with a low forecast of 14.14 USD and a high forecast of 23.1 USD.

Lowest
Price Target
14.14 USD
15% Downside
Average
Price Target
17.54 USD
5% Upside
Highest
Price Target
23.1 USD
38% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

10X Genomics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TXG is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TXG Insider Trading
Buy and sell transactions by insiders

TXG News

Other Videos
What is the Intrinsic Value of one TXG stock?

The intrinsic value of one TXG stock under the Base Case scenario is 21.93 USD.

Is TXG stock undervalued or overvalued?

Compared to the current market price of 16.69 USD, 10X Genomics Inc is Undervalued by 24%.

Back to Top